 |
N-[2,6-bis(1-methylethyl)phenyl]-N’-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt |
|---|---|
| Trade Name | |
| Orphan Indication | Cushing’s syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2015-01-07 00:00:00 |
| Sponsor | Millendo Therapeutics, Inc.;301 North Main St., Suite 100;Ann Arbor,, Michigan, 48104 |
Related Access Program